TargetMol

Metrizamide

Product Code:
 
TAR-T33369
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T33369-5mg5mg£627.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Metrizamide is a nonionic radiopaque contrast agent.
CAS:
31112-62-6
Formula:
C18H22I3N3O8
Molecular Weight:
789.1
Purity:
0.98
SMILES:
CN(C(C)=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)c1I

References

Alm?n T. Angiography with metrizamide. Animal experiments and preliminary clinical experiences. Acta Radiol Suppl. 1977;355:419-30. Review. PubMed PMID: 400907. Hanus PM. Metrizamide: a review with emphasis on drug interactions. Am J Hosp Pharm. 1980 Apr;37(4):510-3. Review. PubMed PMID: 6103672. Salvesen S. Experimental investigations with metrizamide with relevance to the myelographic use. Acta Radiol Suppl. 1977;355:9-13. Review. PubMed PMID: 400909. Grobovschek M. [Lumbosacral functional myelography including the dorsolumbar transitional region (medullary cone). Clinical comparative studies--2000 myelographies with metrizamide]. Radiologe. 1984 Aug;24(8):389-98. Review. German. PubMed PMID: 6237384.